Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 12604

1.

PPAR-γ: Its ligand and its regulation by microRNAs.

Seiri P, Abi A, Soukhtanloo M.

J Cell Biochem. 2019 Feb 15. doi: 10.1002/jcb.28419. [Epub ahead of print]

PMID:
30770587
2.

Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.

Mirza R, Sharma B.

Brain Res Bull. 2019 Feb 12. pii: S0361-9230(18)30873-6. doi: 10.1016/j.brainresbull.2019.02.003. [Epub ahead of print]

PMID:
30769127
3.

Structure based Docking and Molecular dynamics studies: Peroxisome proliferator-activated receptors -α/γ dual agonists for treatment of metabolic disorders.

Nath V, Agrawal R, Kumar V.

J Biomol Struct Dyn. 2019 Feb 15:1-14. doi: 10.1080/07391102.2019.1581089. [Epub ahead of print]

PMID:
30767625
4.

Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin Interacting Protein.

Yuan J, Tan JT, Rajamani K, Solly EL, King EJ, Lecce L, Simpson PJ, Lam YT, Jenkins AJ, Bursill CA, Keech AC, Ng MK.

Diabetes. 2019 Feb 14. pii: db170926. doi: 10.2337/db17-0926. [Epub ahead of print]

PMID:
30765336
5.

Differential Recovery Speed of Activity and Metabolic Rhythms in Rats After an Experimental Protocol of Shift-Work.

Saderi N, Báez-Ruiz A, Azuara-Álvarez LE, Escobar C, Salgado-Delgado RC.

J Biol Rhythms. 2019 Feb 15:748730419828534. doi: 10.1177/0748730419828534. [Epub ahead of print]

PMID:
30764694
6.

Attenuated Lymphatic Proliferation Ameliorates Diabetic Nephropathy and High-Fat Diet-Induced Renal Lipotoxicity.

Kim Y, Hwang SD, Lim JH, Kim MY, Kim EN, Choi BS, Kim YS, Kim HW, Park CW.

Sci Rep. 2019 Feb 13;9(1):1994. doi: 10.1038/s41598-018-38250-7.

7.

In Silico Identification and Experimental Validation of (-)-Muqubilin A, a Marine Norterpene Peroxide, as PPARα/γ-RXRα Agonist and RARα Positive Allosteric Modulator.

D'Aniello E, Iannotti FA, Falkenberg LG, Martella A, Gentile A, De Maio F, Ciavatta ML, Gavagnin M, Waxman JS, Di Marzo V, Amodeo P, Vitale RM.

Mar Drugs. 2019 Feb 12;17(2). pii: E110. doi: 10.3390/md17020110.

8.

Aspirin-Dependent Effects on Purinergic P2Y1 Receptor Expression.

Massimi I, Alemanno L, Guarino ML, Guerriero R, Mancone M, Ceccacci A, Frati L, Angiolillo DJ, Pulcinelli FM.

Thromb Haemost. 2019 Feb 13. doi: 10.1055/s-0039-1678707. [Epub ahead of print]

PMID:
30759486
9.

Effects of lysine deficiency or excess on growth and the expression of lipid metabolism genes in slow-growing broilers.

Tian DL, Guo RJ, Li YM, Chen PP, Zi BB, Wang JJ, Liu RF, Min YN, Wang ZP, Niu ZY, Liu FZ.

Poult Sci. 2019 Feb 9. doi: 10.3382/ps/pez041. [Epub ahead of print]

PMID:
30753620
10.

MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation.

Huang YH, Kuo HC, Yang YL, Wang FS.

Int J Med Sci. 2019 Jan 1;16(2):212-220. doi: 10.7150/ijms.29930. eCollection 2019.

11.

Glycogen Synthase Kinase-3α Promotes Fatty Acid Uptake and Lipotoxic Cardiomyopathy.

Nakamura M, Liu T, Husain S, Zhai P, Warren JS, Hsu CP, Matsuda T, Phiel CJ, Cox JE, Tian B, Li H, Sadoshima J.

Cell Metab. 2019 Feb 2. pii: S1550-4131(19)30005-1. doi: 10.1016/j.cmet.2019.01.005. [Epub ahead of print]

PMID:
30745182
12.

Weight loss effect of sweet orange essential oil microcapsules on obese SD rats induced by high-fat diet.

Li D, Wu H, Dou H.

Biosci Biotechnol Biochem. 2019 Feb 11:1-10. doi: 10.1080/09168451.2019.1578640. [Epub ahead of print]

PMID:
30741117
13.

Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications.

Mirza AZ, Althagafi II, Shamshad H.

Eur J Med Chem. 2019 Feb 1;166:502-513. doi: 10.1016/j.ejmech.2019.01.067. [Epub ahead of print] Review.

PMID:
30739829
14.

Antiobesity efficacy of asiatic acid: down-regulation of adipogenic and inflammatory processes in high fat diet induced obese rats.

Uddandrao VVS, Rameshreddy P, Brahmanaidu P, Ponnusamy P, Balakrishnan S, Ramavat RN, Swapna K, Pothani S, Nemani H, Meriga B, Vadivukkarasi S, P R N, Ganapathy S.

Arch Physiol Biochem. 2019 Feb 10:1-10. doi: 10.1080/13813455.2018.1555668. [Epub ahead of print]

PMID:
30739501
15.

MITOCHONDRIAL-RELATED GENE ASSOCIATED TO OBESITY CAN BE MODULATED BY IN UTERO HYPERGLYCEMIC ENVIRONMENT.

Silveira MAD, Marcondes JPC, Lara JR, Scarano WR, Calderón IMP, Rudge MVC, Salvadori DMF.

Reprod Toxicol. 2019 Feb 6. pii: S0890-6238(18)30230-2. doi: 10.1016/j.reprotox.2019.02.001. [Epub ahead of print]

PMID:
30738174
16.

Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis.

Hassan NF, Nada SA, Hassan A, El-Ansary MR, Al-Shorbagy MY, Abdelsalam RM.

Inflammation. 2019 Feb 9. doi: 10.1007/s10753-019-00967-6. [Epub ahead of print]

PMID:
30737662
17.

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment.

Yokote K, Yamashita S, Arai H, Araki E, Suganami H, Ishibashi S, Of The K-Study Group OB.

Int J Mol Sci. 2019 Feb 6;20(3). pii: E706. doi: 10.3390/ijms20030706.

18.

Naoxintong Retards Atherosclerosis by Inhibiting Foam Cell Formation through Activating PPARα Pathway.

Wang Z, Ge J, Sun A, Shi H, Zhao H, Dong Z, Zhao B, Weng X, Liu R, Li X, Hu K, Zou Y.

Curr Mol Med. 2019 Feb 7. doi: 10.2174/1566524019666190207143207. [Epub ahead of print]

PMID:
30734676
19.

MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism.

Kim SH, Hong SH, Park YJ, Sung JH, Suh W, Lee KW, Jung K, Lim C, Kim JH, Kim H, Park KS, Park SG.

Sci Rep. 2019 Feb 7;9(1):1656. doi: 10.1038/s41598-018-38281-0.

20.

Chondroprotection of PPARα activation by WY14643 via autophagy involving Akt and ERK in LPS-treated mouse chondrocytes and osteoarthritis model.

Zhou Y, Chen X, Qu N, Zhang B, Xia C.

J Cell Mol Med. 2019 Feb 7. doi: 10.1111/jcmm.14184. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center